SFX by Ex Libris Inc.

Title:	A Fluorometric Screening Assay for Drug Efflux Transporter Activity in the Blood-Brain Barrier
Source:	Pharmaceutical Research [0724-8741] Bachmeier, Corbin yr:2005

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Miller, C. "In vitro and in vivo models for assessing drug efflux transporter activity." Advanced Drug Delivery Reviews 55.1 (2002): 31-51.
description	2.	Schinkel, Alfred H. "P-glycoprotein, a gatekeeper in the blood-brain barrier." Advanced drug delivery reviews 36.2-3 (1999): 179-194.
description	3.	Schmid, D. "Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements." Biochemical pharmacology 58.9 (1999): 1447-1456.
description	4.	Loscher, W. "Drug resistance in brain diseases and the role of drug efflux transporters." Nature reviews. Neuroscience 6.8 (2005): 591-602.
description	5.	Agu, R. "In vitro and in vivo testing methods for respiratory drug delivery." Expert opinion on drug delivery 8.1 (2011): 57-69.
description	6.	Meaden, D. "Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo." Journal of immunological methods 262.1-2 (2002): 159-165.
description	7.	Chang, C. "In silico strategies for modeling membrane transporter function." Drug discovery today 10.9 (2005): 663-71.
description	8.	Pardridge, William M. "Transport of small molecules through the blood-brain barrier: biology and methodology." Advanced drug delivery reviews 15.1-3 (1995): 5-36.
description	9.	Kaal, Evert C A C. "The management of brain edema in brain tumors." Current opinion in oncology 16.6: 593-600.
description	10.	SCHINKEL, H P H. "DISRUPTION OF THE MOUSE MDR1A P-GLYCOPROTEIN GENE LEADS TO A DEFICIENCY IN THE BLOOD-BRAIN-BARRIER AND TO INCREASED SENSITIVITY TO DRUGS." Cell 77.4 (1994): 491-502.
description	11.	LINNET, K. "A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs." European Neuropsychopharmacology 18.3 (2008): 157-69.
description	12.	Fromm, Martin F. "Importance of P-glycoprotein at blood-tissue barriers." Trends in pharmacological sciences 25.8 (2004): 423-429.
description	13.	Hermann, Claudio L M. "Implications of ATP-binding cassette transporters for brain pharmacotherapies." Trends in Pharmacological Sciences 28.3 (2007): 128-34.
description	14.	Loscher, W. "Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases." Progress in Neurobiology 76.1 (2005): 22-76.
description	15.	Romsicki, Y. "The membrane lipid environment modulates drug interactions with the P- glycoprotein multidrug transporter." Biochemistry 38.21 (1999): 6887-6896.
description	16.	Hendrich, A B B. "Lipids as a target for drugs modulating multidrug resistance of cancer cells." Current drug targets 4.1 (2002): 23-30.
description	17.	Löscher, W. "Blood-brain barrier active efflux transporters: ATP-binding cassette gene family." NeuroRx 2.1 (2004): 86-98.
description	18.	Vecht, C J J. "Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day." Neurology 44.4 (1994): 675-80.
description	19.	Fromm, M F F. "Importance of P-glycoprotein for drug disposition in humans." European journal of clinical investigation 33.SUPPL (2003): 6-9.
description	20.	Pardridge, William M M. "Blood-brain barrier delivery." Drug discovery today 12.1-2 (2006): 54-61.